-
Cancer ruling benefits cheap drugs in India: Experts 15 March 2012
A provision of the Indian Patents Act allows for a compulsory license to be awarded after three years of the grant of patent on drugs that are deemed to be too costly. Other patent rulings are imminent. A long-running case...
Keywords: Swiss drug maker Novartis, cancer drug Glivec, Thailand, Nexavar drug
Read More
Homepage